Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Consultation record

Consultations on governance document documents

8 consultations on documents of this type.

Consultations

8 documents
  • CEI-CP-037ClosedGovernance document04 Feb 2025 – 05 Apr 2025

    Consultation on the print and archival format for Institute documents: what a printed copy must carry so that it remains checkable when detached from the site, and what an archival copy must preserve.

    18 submissions4 not accepted
  • CEI-CP-029ClosedGovernance document07 Feb 2025 – 24 Mar 2025

    Consultation on the terms governing the Institute's calculators. The draft states that a calculator implements a published formula, that it holds no user data, and that its output is a computation and not clinical advice.

    18 submissions3 not accepted
  • CEI-CP-013ClosedGovernance document01 Nov 2024 – 01 Dec 2024

    Consultation on how the Institute should label a programme record it has constructed by grouping trials, as distinct from a programme as defined by its sponsor. The draft proposes a standing notice on every constructed record stating who…

    13 submissions3 not accepted
  • CEI-CP-012ClosedGovernance document24 Jul 2024 – 18 Sep 2024

    Consultation on the policy governing how the Institute cites evidence. The draft requires that every citation resolve to a retrievable source, that an identifier the Institute does not hold be recorded as not held rather than…

    9 submissions2 not accepted
  • CEI-CP-022ClosedGovernance document16 Jul 2024 – 13 Aug 2024

    Consultation on the policy governing how the Institute corrects a published document and how versions are numbered, retained and linked. The draft retains every superseded version at a stable address and requires that a correction state…

    19 submissions2 not accepted
  • CEI-CP-021ClosedGovernance document01 May 2024 – 30 Jun 2024

    Consultation on the policy governing the public register of Institute members, reviewers, correspondents and contributors: who appears, what is published about each, and what is not. The draft publishes affiliation and declared interests…

    13 submissions2 not accepted
  • CEI-CP-010ClosedGovernance document26 Jan 2023 – 23 Mar 2023

    Consultation on the policy governing the declaration and management of interests across the Institute, covering assessment committee members, external reviewers, contributors and respondents to consultations. The draft proceeds from the…

    12 submissions3 not accepted
  • CEI-CP-011ClosedGovernance document09 Jan 2023 – 10 Mar 2023

    Consultation on the policy governing what funding the Institute accepts, from whom, and on what published terms. The draft prohibits any funding arrangement that confers rights of review over an assessment before publication, and requires…

    10 submissions3 not accepted
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.